Observed Signal · Aug 25, 2026 · Market Signal · Source: HTGF | High-Tech Gründerfonds · Impact: 4/5
REVIER Therapeutics Launches with €6 Million Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease
REVIER Therapeutics announced the successful closing of a €6 million seed financing round and the official start of operations. The company is developing first-in-class selective Class IIa HDAC inhibitors for cardiometabolic diseases, with lead programs in HFpEF and ASCVD. The round was led by KHAN Technology Transfer Fund II, with participation from HTGF, VORNvc, and private investors via Revier Invest Heidelberg.
Track HTGF | High-Tech Gründerfonds Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Enveda raises $311M for AI drug discovery
Enveda, an AI-driven biotech startup focused on discovering drugs from natural sources, has raised $311 million in a Series E funding round at a $2 billion valuation. The round was led by Catalio Capital Management, with participation from Iconiq and others, doubling the company's valuation from 12 months ago. Enveda, founded in 2019 by Viswa Colluru, uses AI to accelerate the discovery of drugs from plants and microbes. The startup is currently advancing several drug candidates into clinical trials, including treatments for severe skin conditions and a drug designed to maintain weight loss after discontinuation of GLP-1s. This funding will support further clinical development.
Reverion raises $175M, plans factory with 800 jobs
Reverion, a Bavarian energy-tech startup, has raised $175 million (€154.2 million) in its largest Series B round, led by climate-tech fund Kembara, with participation from Allianz, KfW Capital, Aurum Impact, and Carbon Equity. The funds will support a new megafactory in Germany, with a site of about 100,000 square meters (30,000 for buildings), boosting annual production capacity to 250 MW and creating up to 800 jobs, including roles for skilled blue-collar workers. Reverion's reversible solid-oxide fuel cell (SOFC) power plants achieve 74.2% electrical efficiency, can switch to electrolysis to store surplus renewable energy as gas, and capture CO2, enabling carbon-neutral or carbon-negative operation. Targeting AI data centers and heavy industry to address solar and wind intermittency, the company has seven plants operating at customer sites and a project pipeline exceeding $2 billion, with international deliveries planned.
Revving Revolutionizes Ad Funding with Real-Time API Solutions
Quo Vadis published an interview with Revving co‑founders (Chris and David) describing Revving’s transaction-based funding product for the adtech supply chain. Revving integrates with DSPs and SSPs via APIs to ingest real‑time transaction data and underwrite advances based on delivery and payer quality. The company positions its solution as an evolution of invoice factoring (no setup fees, no minimum utilization, no debtor notifications, no asset-wide liens) and offers RevHub, a unified reporting and reconciliation layer. Revving has raised £107m (£7m equity and £100m funding capacity), is expanding aggressively in the U.S., and is embedding AI/agentic workflows to scale operations. The post also lists two upcoming industry events in New York City in February and March 2026.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.